Samjo Capital’s AstraZeneca AZN Stock Holding History

Samjo Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	$3.3M	Buy	+24,360	New	+$3.33M	1.3%	13

Other funds holding AZN

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Samjo Capital's AZN Position: Q3 2023 in Review

Samjo Capital opened a new position in AstraZeneca (AZN) in Q3 2023: 24,360 shares worth $3.3M. The stake represents 1.3% of the portfolio and ranks #13 among its holdings.

1,074 funds tracked by Wall St. Rank hold AZN as of Q3 2023.

Samjo Capital held 24,360 shares of AstraZeneca worth $3.3M as of Q3 2023.
AstraZeneca was a new Samjo Capital position in Q3 2023.
AstraZeneca made up 1.3% of Samjo Capital's portfolio in Q3 2023, its #13 holding.
1,074 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2023.

Based on Samjo Capital's 13F filing for Q3 2023, filed 14 Nov 2023.